According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is $0.88. In 2022 the company made an earnings per share (EPS) of $0.95 a decrease over its 2021 EPS that were of $0.97.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.88 | -7.37% |
2022 | $0.95 | -2.06% |
2021 | $0.97 | 5.43% |
2020 | $0.92 | 10.84% |
2019 | $0.83 | 27.69% |
2018 | $0.65 | -42.48% |
2017 | $1.13 | 1518.29% |
2016 | $0.06983 | -199.75% |
2015 | -$0.07000 | -77.42% |
2014 | -$0.31 | -32.61% |
2013 | -$0.46 | 12.2% |
2012 | -$0.41 | 2.5% |
2011 | -$0.40 | 2.56% |
2010 | -$0.39 | 2.63% |
2009 | -$0.38 | -11.63% |
2008 | -$0.43 | 26.47% |
2007 | -$0.34 | -68.81% |
2006 | -$1.09 | 23.86% |
2005 | -$0.88 | -1.12% |
2004 | -$0.89 | -27.05% |
2003 | -$1.22 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | 1,500.60% | ๐บ๐ธ USA |
Novartis NVS | $3.74 | 325.00% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | 111.36% | ๐บ๐ธ USA |
Eli Lilly LLY | $5.43 | 516.96% | ๐บ๐ธ USA |
Merck MRK | $1.82 | 107.01% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $3.97 | 351.14% | ๐บ๐ธ USA |
MannKind Corp MNKD | -$0.19 | -121.59% | ๐บ๐ธ USA |
Esperion Therapeutics ESPR | -$2.82 | -420.45% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $0.78 | -11.52% | ๐บ๐ธ USA |